Allspring Global Investments Holdings LLC Decreases Stock Holdings in UnitedHealth Group Incorporated $UNH

Allspring Global Investments Holdings LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 24.7% in the second quarter, Holdings Channel.com reports. The institutional investor owned 271,075 shares of the healthcare conglomerate’s stock after selling 89,008 shares during the period. Allspring Global Investments Holdings LLC’s holdings in UnitedHealth Group were worth $88,408,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of UNH. Bayforest Capital Ltd increased its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd increased its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. Kentucky Trust Co increased its position in shares of UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. O Brien Wealth Partners LLC increased its position in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares during the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $53,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH stock opened at $358.80 on Tuesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s fifty day simple moving average is $320.57 and its two-hundred day simple moving average is $346.99. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The firm has a market cap of $324.96 billion, a price-to-earnings ratio of 15.55, a PEG ratio of 2.29 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the business earned $6.80 EPS. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Truist Financial boosted their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research note on Tuesday, September 9th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Bank of America upped their price target on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $379.00 to $433.00 and gave the stock an “outperform” rating in a report on Wednesday, October 8th. Finally, Wells Fargo & Company upped their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.